Cerevel Therapeutics Holdings, Inc. Quarterly Common Stock, Shares, Issued from Q4 2019 to Q1 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Cerevel Therapeutics Holdings, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2019 to Q1 2024.
  • Cerevel Therapeutics Holdings, Inc. Common Stock, Shares, Issued for the quarter ending March 31, 2024 was 182M shares, a 16% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 182M +25.1M +16% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 181M +24.9M +15.9% Dec 31, 2023 10-Q 2024-05-08
Q3 2023 158M +1.32M +0.85% Sep 30, 2023 10-Q 2023-11-01
Q2 2023 157M +8.98M +6.05% Jun 30, 2023 10-Q 2023-08-02
Q1 2023 157M +8.58M +5.79% Mar 31, 2023 10-Q 2023-05-03
Q4 2022 157M +8.78M +5.95% Dec 31, 2022 10-K 2024-02-27
Q3 2022 156M +9.11M +6.19% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 148M +20.8M +16.3% Jun 30, 2022 10-Q 2022-08-01
Q1 2022 148M +20.9M +16.4% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 148M +20.6M +16.2% Dec 31, 2021 10-K 2023-02-22
Q3 2021 147M Sep 30, 2021 10-Q 2021-11-10
Q2 2021 128M Jun 30, 2021 10-Q 2021-08-11
Q1 2021 127M Mar 31, 2021 10-Q 2021-05-17
Q4 2020 127M +66.2M +109% Dec 31, 2020 10-K 2022-03-01
Q4 2019 60.9M Dec 31, 2019 10-K 2021-03-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.